Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

l-Dopa in dystonia: A modern perspective.

Roderick P P W M Maas1, Tessa Wassenberg2, Jean-Pierre Lin2

  • 1From the Department of Neurology (R.P.P.W.M.M., T.W., B.P.C.v.d.W.), Donders Institute for Brain, Cognition, and Behaviour (R.P.P.W.M.M., T.W., B.P.C.v.d.W., M.A.A.P.W.), and Department of Pediatric Neurology (M.A.A.P.W.), Radboud University Medical Center, Nijmegen, the Netherlands; and Complex Motor Disorders Service (J.-P.L.), Children's Neurosciences, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. roderick.maas@radboudumc.nl.

Neurology
|April 9, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma Copper and Zinc Levels in Ataxia-Telangiectasia.

International journal of molecular sciences·2026
Same author

A potential turn of the tide in ataxia-telangiectasia.

The Lancet. Neurology·2026
Same author

Loss of astrocytic markers and impaired metabolic function in spinocerebellar ataxia type 7 patient-derived neural cultures.

Neurobiology of disease·2026
Same author

Climate change and pediatric neurology: A call to action.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society·2026
Same author

Clinical challenges following early detection of ataxia telangiectasia through SCID newborn screening.

Journal of human immunity·2026
Same author

Mental health issues in cerebellar disorders.

Neuroscience and biobehavioral reviews·2026

The adage of giving every child with dystonia an l-dopa trial is outdated. Current evidence suggests a more targeted approach, using l-dopa only after specific diagnostic confirmations for dopa-responsive dystonia (DRD) or in select cases.

Area of Science:

  • Neurology
  • Movement Disorders
  • Genetics

Background:

  • The long-standing recommendation for empirical l-dopa trials in all children with dystonia is being re-evaluated.
  • Advances in understanding dystonia's causes and diagnostic tools necessitate a shift from universal empirical trials.

Purpose of the Study:

  • To provide a historical perspective on l-dopa trials for dystonia.
  • To critically assess the current diagnostic and therapeutic use of l-dopa in neurologic practice.
  • To propose updated guidelines for l-dopa use in pediatric and adult dystonia.

Main Methods:

  • Historical review of l-dopa use in dystonia.
  • Analysis of current clinical practices versus approved indications for l-dopa.
  • Literature review on therapeutic l-dopa trials in various dystonia types.

Related Experiment Videos

Main Results:

  • Empirical l-dopa trials are considered outdated for early-onset dystonia (≤25 years) in high-resource settings.
  • Suggested l-dopa use: after biochemical/genetic confirmation of DRD or nuclear imaging in adult lower limb dystonia.
  • L-dopa may offer symptomatic relief in selected non-DRD cases.

Conclusions:

  • Rethinking the universal l-dopa trial for early-onset dystonia is crucial.
  • A rational, evidence-based approach to l-dopa therapy in dystonia is advocated.
  • Personalized l-dopa treatment strategies are recommended based on diagnosis and patient characteristics.